Differential regulation of cutaneous oncoprotein HPVE6 by wtp53, mutant p53R248W and ΔNp63α is HPV type dependent

PLoS ONE

Volumn 7, Issue 4, 2012, Pages

  Fei, Jian Wei ^a   de Villiers, Ethel Michele ^a  

^a Division for the Characterization of Tumorviruses   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CYCLIN D1; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 2A; DELTANP63ALPHA PROTEIN; MUTANT PROTEIN; PROTEASOME; PROTEIN C JUN; PROTEIN HPV20E6; PROTEIN HPVE6; PROTEIN P53; PROTEIN P63; PROTEIN WTP53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER CELL CULTURE; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL KINETICS; CELL PROLIFERATION; CONTROLLED STUDY; DELTANP63ALPHA GENE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; HPVE6 GENE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 27; HUMAN PAPILLOMAVIRUS TYPE 38; HUMAN PAPILLOMAVIRUS TYPE 4; HUMAN PAPILLOMAVIRUS TYPE 48; HUMAN PAPILLOMAVIRUS TYPE 5; HUMAN PAPILLOMAVIRUS TYPE 60; HUMAN PAPILLOMAVIRUS TYPE 7; HUMAN PAPILLOMAVIRUS TYPE 77; HUMAN TISSUE; KERATINOCYTE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; UPREGULATION; VIRUS GENE; WART VIRUS; WTP53 GENE;

AMINO ACID SUBSTITUTION; APOPTOSIS; CELL LINE; CELL PROLIFERATION; CYCLIN D1; CYCLIN-DEPENDENT KINASE 6; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; HUMANS; KERATINOCYTES; MUTATION; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN BINDING; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 84859970127     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0035540     Document Type: Article

References (64)

1. Astori G, Lavergne D, Benton C, Höckmayr B, Egawa K, et al. (1998) Human papillomaviruses are commonly found in normal skin of immunocompetent hosts. J Invest Dermatol 110: 752-755.
2. Antonsson A, Forslund O, Ekberg H, Stemer G, Hansson BG, (2000) The ubiquity and impressive genomic diversity of human skin papillomaviruses suggest a comensalic nature of these viruses. J Virol 74: 11636-11641.
3. Forslund O, Iftner T, Andersson K, Lindelöf B, Hradil E, et al. (2007) Cutaneous human papillomaviruses found in sun-exposed skin: Beta-papillomavirus species 2 predominates in squamous cell carcinoma. J Infect Dis 196: 876-883.
4. Asgari M, Kiviat NB, Critchlow CW, Stern JE, Argenyi Z, et al. (2008) Detection of human papillomavirus DNA in cutaneous squamous cell carcinoma among immunocompetent individuals. J Invest Dermatol 128: 1409-1417.
5. Chen AC, McMillan NA, Antonsson A, (2008) Human papillomavirus type spectrum in normal skin of individuals with or without a history of frequent sun exposure. J Gen Virol 89: 2891-2897.
6. de Koning MN, Weissenborn SJ, Abeni D, Bouwes Bavinck JN, Euvrard S, et al. (2009) Prevalence and associated factors of betapapillomavirus infections in individuals without cutaneous squamous cell carcinoma. J Gen Virol 90: 1611-1621.
7. Plasmeijer EI, Neale RE, Buettner PG, de Koning MN, Ter Schegget J, et al. (2010) Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients. Int J Cancer 126: 2614-2621.
8. Ekström J, Bzhalava D, Svenback D, Forslund O, Dillner J, (2011) High throughput sequencing reveals diversity of human papillomaviruses in cutaneous lesions. Int J Cancer 129: 2643-2650.
9. Mantovani F, Banks L, (2001) The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20: 7874-7887.
10. zur Hausen H, (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350.
11. Pim D, Thomas M, Banks L, (2002) Chimaeric HPV E6 proteins allow dissection of the proteolytic pathways regulating different E6 cellular target proteins. Oncogene 21: 8140-8148.
12. Howie HL, Katzenellenbogen RA, Galloway DA, (2009) Papillomavirus E6 proteins. Virology 384: 324-334.
13. Fei JW, de Villiers EM, (2008) Degradation of HPV20E6 by p53: ΔNp63α and mutant p53R248W protect the wild type p53 mediated caspase-degradation. Int J Cancer 123: 108-116.
14. Ghittoni R, Accardi R, Hasan U, Gheit T, Sylla B, et al. (2010) The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 40: 1-13.
15. de Villiers E-M, Fauquet C, Bernard H-U, Broker T, zur Hausen H, (2004) Classification of Papillomaviruses. Virology 324: 17-27.
16. Bernard HU, Burk RD, Chen Z, van Doorslaer K, Hausen H, et al. (2010) Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
17. Bedard KM, Underbrink MP, Howie HL, Galloway DA, (2008) The E6 oncoproteins from human betapapillomaviruses differentially activate telomerase through an E6AP-dependent mechanism and prolong the lifespan of primary keratinocytes. J Virol 82: 3894-3902.
18. Gabet A-S, Accardi R, Bellopede A, Popp S, Boukamp P, et al. (2008) Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38. FASEB J 22: 622-632.
19. Kiyono T, Hiraiwa A, Ishibashi M, (1992) Differences in transforming activity and coded amino acid sequence among E6 genes of several papillomaviruses associated with epidermodysplasia verruciformis. Virology 186: 628-639.
20. Massimi P, Thomas M, Bouvard V, Ruberto I, Campo MS, et al. (2008) Comparative transforming potential of different human papillomaviruses associated with non-melanoma skin cancer. Virology 371: 374-379.
21. Ziegler A, Leffell DJ, Kunala S, Sharma HW, Gailani M, et al. (1993) Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci USA 90: 4216-4220.
22. Brash DE, Rudolf JA, Simon JA, Kin A, McKenna GJ, et al. (1991) A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88: 10124-10128.
23. Oliver M, Eeles R, Hollstein M, Khan MA, Harris CC, et al. (2002) The IARC p53 Database: new online mutation analysis and recommendations to users. Hum Mutat 19: 607-614.
24. Dell'Orso S, Fontemaggi G, Stambolsky P, Goeman F, Voellenkle C, et al. (2011) ChIP-on-chip analysis of in vivo mutant p53 binding to selected gene promoters. OMICS 15: 305-312.
25. Aylon Y, Oren M, (2011) New plays in the p53 theater. Curr Opinion Gen Develop 21: 86-92.
26. Xu J, Couceiro JR, De Smet F, Gallrado R, Rudyak S, et al. (2011) Gain of function of mutant p53 by coaggregation with multiple tumor suppressors. Nat Chem Biol 7: 285-295.
27. Melino G, (2011) p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53. Cel Death Diff 18: 1487-1499.
28. Su X, Cho MS, Gi Y-J, Ayanga BA, Sherr CJ, et al. (2009) Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. EMBO J 28: 1904-1915.
29. Flores ER, (2007) The roles of p63 in cancer. Cell Cycle 6: 300-304.
30. Petitjean A, Ruptier C, Tribollet V, Hautefeauille A, Chardon F, et al. (2008) Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with ΔNp73. Carcinogenesis 29: 273-281.
31. Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, et al. (2000) AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci USA 97: 5462-5467.
32. King KE, Ponnamperuma RM, Allen C, Lu H, Duggal P, et al. (2008) The p53 homologue ΔNp63α interacts with the nuclear factor-κB pathway to modulate epithelial cell growth. Cancer Res 68: 5122-5131.
33. Graziano V, De Laurenzi V, (2011) Role of p63 in cancer development. Biochim Biophys Acta 1816: 57-66.
34. Jackson S, Harwood C, Thomas M, Banks L, Storey A, (2000) Role of Bak in UV-induced apoptosis in skin cancer and abrogation by HPV E6 proteins. Genes & Develop 14: 3065-3073.
35. Struijk L, van der Meijden E, Kazem S, ter Schegget J, de Gruijl FR, et al. (2008) Specific betapapillomaviruses associated with squamous cell carcinoma of the skin inhibit UVB-unduced apoptosis of primary keratinocytes. J Gen Virol 89: 2303-2314.
36. Vasiljevic N, Nielsen L, Doherty G, Dillner J, Forslund O, et al. (2008) Differences in transcriptional activity of cutaneous human papillomaviruses. Virus Res 137: 213-219.
37. Underbrink MP, Howie HL, Bedard KM, Koop JI, Galloway DA, (2008) E6 proteins from multiple human betapapillomavirus types degrade Bak and protect keratinocytes from apoptosis after UVB irradiation. J Virol 82: 10408-10417.
38. Leverrier S, Bergamaschi D, Ghali L, Ola A, Warnes G, et al. (2007) Role of HPV E6 proteins in preventing UVB-induced release of pro-apoptotic factors from the mitochondria. Apoptosis 12: 549-560.
39. de Villiers E-M, Ruhland A, Sekaric P, (1999) Human papillomavirus infections in nonmelanoma skin cancer. Sem Cancer Biol 9: 413-422.
40. Fei J-W, Wei Q-X, Angel P, de Villiers E-M, (2005) Differential enhancement of a cutaneous HPV promoter by p63, Jun and mutant p53. Cell Cycle 4: 689-696.
41. Nobre RJ, Herráez-Hernández E, Fei JW, Langbein L, Kaden S, et al. (2009) E7 oncoprotein of novel human papillomavirus type 108 lacking the E6 gene induces dysplasia in organotypic keratinocyte cultures. J Virol 83: 2907-2916.
42. Lambert PF, Ozbun MA, Collins A, Holmgren S, Lee D, et al. (2005) Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures. Methods Mol Med 119: 141-155.
43. Kawamura K, Morita N, Domiki C, Fujikawa-Yamamoto K, Hashimoto M, et al. (2006) Induction of centrosome amplification in p53 siRNA-treated human fibroblast cells by radiation exposure. Cancer Sci 97: 252-258.
44. Alam S, Bowser BS, Conway MJ, Israr M, Ryndock EJ, et al. (2010) Downregulation of Cdc2/CDK1 kinase activity induces the synthesis of noninfectious human papillomavirus type 31b virions in organotypic tissues exposed to benzo[a]pyrene. J Virol 84: 4630-4645.
45. Van Dross R, Yao S, Asad S, Westlake G, Mays DJ, et al. (2005) Constitutively active K-cyclin/cdk6 kinase in Kaposi sarcoma-associated herpesvirus-infected cells. J Natl Cancer Inst 97: 656-666.
46. Sun Y, Deng D, You WC, Bai H, Zhang L, et al. (2004) Methylation of p16 CpG islands associated with malignant transformation of gastric dysplasia in a population-based study. Clin Cancer Res 10: 5087-5093.
47. Yan J, Jiang J, Lim CA, Wu Q, Ng HH, et al. (2007) BLIMP1 regulates cell growth through repression of p53 transcription. Proc Natl Acad Sci USA 104: 1841-1846.
48. Galluzzi L, Vitale I, Abrams JM, Alnemri ES, Baehrecke EH, et al. (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Diff 19: 107-120.
49. Cain K, (2003) Chemical-induced apoptosis: formation of the Apaf-1 apoptosome. Drug Metab Rev 35: 337-63.
50. Inoue S, Browne G, Melino G, Cohen GM, (2009) Ordering of caspases in cells undergoing apoptosis by the intrinsic pathway. Cell Death Diff 16: 1053-1061.
51. Eisenberg-Lerner A, Bialik S, Simon H-U, Kimchi A, (2009) Life and death partners: apoptosis, autophagy and the cross-talk between them. Cell Death Diff 16: 966-975.
52. Ortega S, Malumbres M, Barbacid M, (2002) Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochim Biophys Acta 1602: 73-78.
53. Sablina AA, Hahn WC, (2008) SV40 small T antigen and PP2A phosphatase in cell transformation. Cancer Metastasis Rev 27: 137-146.
54. Westermarck J, Hahn WC, (2008) Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 14: 152-160.
55. Tashiro E, Tsuchiya A, Imoto M, (2007) Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 98: 629-635.
56. Larsson L-G, (2011) Oncogene- and tumor suppressor gene-mediated suppression of cellular senescence. Sem Cancer Biol 21: 367-376.
57. Arron ST, Ruby JG, Dybbro E, Ganem D, Derisi JL, (2011) Transcriptome sequencing demonstrates that human papillomavirus is not active in cutaneous squamous cell carcinoma. J Invest Dermatol 131: 1745-1753.
58. Michel A, Kopp-Schneider A, Zentgraf H, Gruber AD, de Villiers E-M, (2006) E6/E7 expression of HPV20 and HPV27 influences proliferation and differentiation of the skin in UV-irradiated SKH-hr1 transgenic mice. J Virol 80: 11153-11164.
59. Fei J-W, Angel P, Wei Q-X, de Villiers E-M, (2006) TAp63α indirectly regulates a cutaneous HPV promoter through complex formation with Jun family members. Oncogene 25: 3914-3924.
60. Woods M, Pant R, Mallya SM, (2010) Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation. Int J Oncol 37: 1471-1475.
61. Wang X, Sistrunk C, Rodriguez-Puebla ML, (2011) Unexpected reduction of skin tumorigenesis on expression of cyclin-dependent kinase 6 in mouse epidermis. Am J Pathol 178: 345-354.
62. Takahashi A, Ohtani N, Hara E, (2007) Irreversibility of cellular senescence: dual role of p16INK4a/Rb-pathway in cell cycle control. Cell Div 2: 10.
63. Pim D, Massimi P, Dilworth SM, Banks L, (2005) Activation of the protein kinase B pathway by the HPV-16 E7 oncoprotein occurs through a mechanism involving interaction with PP2A. Oncogene 24: 7830-7838.
64. Goldstein I, Marcel V, Olivier M, Oren M, Rotter V, et al. (2011) Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies. Cancer Gene Ther 18: 2-11.